Pharma ETFs in Focus Post Q2 Earnings By: TalkMarkets August 11, 2023 at 15:12 PM EDT Second-quarter earnings for the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 30.7% on 5% revenue growth. Read More >> Related Stocks: Bristol-Myers Squibb Dynamic Pharmaceuticals Invesco ETF Eli Lilly Johnson & Johnson Merck & Co Nasdaq Pharmaceuticals ETF Pfizer S&P Pharmaceuticals SPDR US Pharmaceuticals Ishares ETF Vaneck Pharmaceutical ETF
